4//SEC Filing
Klowden Michael 4
Accession 0001213900-24-107607
CIK 0001845459other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 9:56 PM ET
Size
8.2 KB
Accession
0001213900-24-107607
Insider Transaction Report
Form 4
Klowden Michael
Director
Transactions
- Award
Stock Option (right to buy)
2024-12-06+300,000→ 300,000 totalExercise: $1.62Exp: 2034-12-06→ Common Stock (300,000 underlying) - Award
Stock Option (right to buy)
2024-12-06+500,000→ 500,000 totalExercise: $0.44Exp: 2034-12-06→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]On December 6, 2024, the Reporting Person was granted 300,000 options pursuant to the Company's 2023 Equity Incentive Plan, with 40% vesting immediately as of the grant date, and the remaining options vesting in 20 equal installments on the sixth day of each month, beginning January 6, 2025, and ending August 6, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]On December 6, 2024, the Reporting Person was granted 500,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in 36 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date
Documents
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeother
Related Parties
1- filerCIK 0001991117
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 9:56 PM ET
- Size
- 8.2 KB